Guinea-Bissau suspends a US-funded vaccine trial as African scientists question its motives

Guinea-Bissau will implement a universal birth-dose policy for the Hepatitis B vaccine in 2027.Credit: Enrique ...

Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial

Trial participants Our study population comprised individuals aged 18 years or older with a diagnosis of ...

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

Oversight The MG-001 part 3 trial was performed in accordance with the principles of the ...

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

Preclinical in vitro experiments Generation of CAR cells and evaluation of CAR expression Primary CD8+ ...

Study design The study design for the DESIRES trial has been previously reported (NCT04274257)30. The ...